Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
The British Journal of Dermatology|February 17, 2024
Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trialDavid T Woodley, Michelle Hao, Andrew Kwong, et al.International Journal of Laboratory Hematology|August 26, 2023
Factors determining whether diffuse large B-cell lymphoma samples are detected by flow cytometryDavid Peng, Aruna Kodituwakku, Steven Le, et al.The Annals of Thoracic Surgery|May 27, 2024
Predicting Stroke for Pediatric Patients Supported With Ventricular Assist Devices: A Pedimacs ReportAwais Ashfaq, Angela Lorts, David Rosenthal, et al.The Annals of Thoracic Surgery|August 13, 2023
Survival in Pediatric Patients With Ventricular Assist Devices: A Special Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) ReportAwais Ashfaq, Angela Lorts, David Rosenthal, et al.Circulation. Arrhythmia and Electrophysiology|December 2, 2025
Predictors of Response to Cardiac Resynchronization Therapy in Pediatric Patients and Patients With Congenital Heart DiseaseHenry Chubb, Douglas Mah, Maully Shah, et al.Oncoimmunology|December 22, 2016
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppressionLimo Chen, Xiaohui Yi, Sangeeta Goswami, et al.Nature Communications|April 14, 2019
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistanceShun Li, Ying Song, Christine Quach, et al.Science Translational Medicine|September 4, 2020
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint componentsMonique B Nilsson, Huiying Sun, Jacqulyne Robichaux, et al.The Journal of Experimental Medicine|October 12, 2020
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodelingCarmine Fedele, Shuai Li, Kai Wen Teng, et al.Cancer Research|August 12, 2021
Targeting HER2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor MobocertinibHan Han, Shuai Li, Ting Chen, et al.Pageof 4